CompuGroup Medical SE & Co. KGaA (HAM:COP)

Germany flag Germany · Delayed Price · Currency is EUR
27.20
-0.05 (-0.18%)
At close: May 20, 2026
Market Cap1.41B +23.0%
Revenue (ttm)1.25B +5.1%
Net Income28.24M -18.4%
EPS0.54 -18.2%
Shares Out51.73M
PE Ratio50.37
Forward PEn/a
Dividend0.55 (2.03%)
Ex-Dividend DateApr 20, 2026
Volume812
Average Volume843
Open27.25
Previous Close27.25
Day's Range27.20 - 27.80
52-Week Range21.98 - 29.00
Betan/a
RSI53.90
Earnings DateMay 18, 2026

About HAM:COP

CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks. This segment also offers solutions that cover all essential clinical, administrative, and billing functions... [Read more]

Founded 1987
Employees 8,700
Stock Exchange Hamburg Stock Exchange
Ticker Symbol COP
Full Company Profile

Financial Performance

In 2025, HAM:COP's revenue was 1.25 billion, an increase of 5.10% compared to the previous year's 1.19 billion. Earnings were 28.24 million, a decrease of -18.37%.

Financial Statements

News

CompuGroup Medical SE & Co. KGaA Quarterly report: Q2 2025

CompuGroup Medical SE & Co. KGaA has published its Q2 2025 quarterly earnings report on July 31, 2025.

10 months ago - Filings

CompuGroup Medical SE & Co. KGaA Slides: Q2 2025

CompuGroup Medical SE & Co. KGaA has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on July 31, 2025.

10 months ago - Filings

EQS-PVR: CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: CompuGroup Medical SE & Co. KGaA CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the o...

11 months ago - Wallstreet:Online

EQS-News: Delisting of CompuGroup Medical to become effective as of 24 June 2025

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Delisting Delisting of CompuGroup Medical to become effective as of 24 June 2025 19.06.2025 / 11:21 CET/CEST The issuer is solely responsible ...

1 year ago - Wallstreet:Online

EQS-News: CompuGroup Medical issues joint reasoned statement recommending shareholders to accept CVC’s public delisting offer

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Delisting CompuGroup Medical issues joint reasoned statement recommending shareholders to accept CVC’s public delisting offer 06.06.2025 / 14:...

1 year ago - Wallstreet:Online

EQS-News: CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Delisting CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC 08.05.2025 / 22:09 CET/CEST The issuer is solely...

1 year ago - Wallstreet:Online

EQS-WpÜG: Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: Caesar BidCo GmbH

EQS-WpÜG: Caesar BidCo GmbH / Tender Offer Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: Caesar BidCo GmbH 08.05.2025 / 22:05 CET/CEST Dissemination of an announcement accor...

1 year ago - Wallstreet:Online

CompuGroup Medical SE & Co. KGaA Earnings Call Transcript: Q1 2025

Q1 2025 saw modest revenue growth of 1% year over year, driven by recurring revenues, while one-time revenues declined. Adjusted EBITDA and EPS fell, but free cash flow improved significantly. Strategic partnership with CVC Capital Partners was finalized, and full-year guidance for low to mid-single-digit organic growth was confirmed.

1 year ago - Transcripts

CompuGroup Medical SE & Co. KGaA Earnings Call Transcript: Q1 2025

Q1 2025 saw modest revenue growth of 1% year over year, driven by recurring revenues, while one-time revenues declined. Adjusted EBITDA and EPS fell, but free cash flow improved significantly. Strategic partnership with CVC Capital Partners was finalized, and full-year guidance for low to mid-single-digit organic growth was confirmed.

1 year ago - Transcripts

CompuGroup Medical SE & Co. KGaA Quarterly report: Q1 2025

CompuGroup Medical SE & Co. KGaA has published its Q1 2025 quarterly earnings report on April 30, 2025.

1 year ago - Filings

CompuGroup Medical SE & Co. KGaA Slides: Q1 2025

CompuGroup Medical SE & Co. KGaA has posted slides in relation to its Q1 2025 quarterly earnings report, which was published on April 30, 2025.

1 year ago - Filings

EQS-PVR: CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: CompuGroup Medical SE & Co. KGaA CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the o...

1 year ago - Wallstreet:Online

Q1/2025: CompuGroup Medical Faces a Slow Start

CompuGroup Medical started 2025 with a slight revenue increase, a strategic financial boost, and a strong focus on innovation, setting the stage for a promising year ahead. Jetzt den vollständigen Art...

1 year ago - Wallstreet:Online

EQS-News: Q1/2025: CompuGroup Medical reports slow start into the year

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Quarterly / Interim Statement/Quarter Results Q1/2025: CompuGroup Medical reports slow start into the year 30.04.2025 / 07:39 CET/CEST The iss...

1 year ago - Wallstreet:Online

EQS-News: Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes effect upon completion of the offer

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes ef...

1 year ago - Wallstreet:Online

EQS-PVR: CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: CompuGroup Medical SE & Co. KGaA CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the o...

1 year ago - Wallstreet:Online

CompuGroup Medical SE & Co. KGaA Earnings Call Transcript: Q4 2024

2024 saw a 2% organic revenue decline, but recurring revenues grew 5% to nearly 75% of total, with adjusted EBITDA at €225 million and free cash flow at €66 million. Strategic acquisitions and a new partnership with CVC set the stage for renewed growth in 2025.

1 year ago - Transcripts

CompuGroup Medical SE & Co. KGaA Earnings Call Transcript: Q4 2024

2024 saw a 2% organic revenue decline, but recurring revenues grew 5% to nearly 75% of total, with adjusted EBITDA at €225 million and free cash flow at €66 million. Strategic acquisitions and a new partnership with CVC set the stage for renewed growth in 2025.

1 year ago - Transcripts

CompuGroup Medical SE & Co. KGaA Annual report: Q4 2024

CompuGroup Medical SE & Co. KGaA has published its Q4 2024 annual report on March 6, 2025.

1 year ago - Filings

CompuGroup Medical SE & Co. KGaA Slides: Q4 2024

CompuGroup Medical SE & Co. KGaA has posted slides in relation to its Q4 2024 quarterly earnings report, which was published on March 6, 2025.

1 year ago - Filings

CompuGroup Medical: FY 2024 Results Align, Growth Expected in 2025

CompuGroup Medical SE & Co. KGaA faced a revenue dip in 2024 but saw a rise in recurring revenues, underscoring stability. With a focus on AI and innovation, the company eyes growth in 2025. Jetzt den...

1 year ago - Wallstreet:Online

CompuGroup Medical Slashes 2024 Dividend to Legal Minimum!

CompuGroup Medical SE & Co. KGaA is steering its financial course towards innovation, opting to slash its 2024 dividend to a mere EUR 0.05 per share, a stark drop from last year's EUR 1.00. Jetzt den ...

1 year ago - Wallstreet:Online

EQS-Adhoc: Ad-hoc: CompuGroup Medical SE & Co. KGaA intends to reduce the annual dividend for the financial year 2024 to the legal minimum

EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Dividend Ad-hoc: CompuGroup Medical SE & Co. KGaA intends to reduce the annual dividend for the financial year 2024 to the legal minimum 04-...

1 year ago - Wallstreet:Online

EQS-News: Final results of voluntary public takeover offer – CVC has secured 21.85% of total share capital and voting rights of CompuGroup Medical

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer Final results of voluntary public takeover offer – CVC has secured 21.85% of total share capital and voting rights of CompuGroup ...

1 year ago - Wallstreet:Online

EQS-News: Successful conclusion of initial acceptance period of CVC offer for CompuGroup Medical – Additional acceptance period from 29 January to 11 February 2025

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous Successful conclusion of initial acceptance period of CVC offer for CompuGroup Medical – Additional acceptance period from 29 Ja...

1 year ago - Wallstreet:Online